Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis
Crossref DOI link: https://doi.org/10.1186/s12872-016-0429-6
Published Online: 2016-12-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiffman, Dov
Arellano, Andre R.
Caulfield, Michael P.
Louie, Judy Z.
Bare, Lance A.
Devlin, James J.
Melander, Olle
License valid from 2016-12-01